Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
19 Patents
#70 in Boulder, CO
#351 in Colorado
#17,167 in US
#32,726 in the World
Nivalis Therapeutics, Inc.
Forward Citations = 37
6 inventors:
Boulder, CO, United States of America
Nivalis Therapeutics, Inc.
Calculating rank
% Expired Patents = 94.7
EPO Patents = 5
Forward Citations = 37
Loading Chart...
Loading Chart...
6 inventors (with patents filed for the assignee):
Jian Qiu (19 out of 38 patents)
Xicheng David Sun (19 out of 49 patents)
Adam Stout (8 out of 10 patents)
4. Jan William Wasley (6 out of 30 patents)
5. Sarah A Strong (5 out of 24 patents)
6. Gary Joseph Rosenthal (5 out of 18 patents)
19 patents:
1. 9856219 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2018-01-02),
2. 9814700 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2017-11-14),
5. 9498466 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2016-11-22),
6. 9433618 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2016-09-06),
8. 9315462 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2016-04-19),
Company Overview
Nivalis Therapeutics, Inc. is a biotechnology company based in Boulder, Colorado, focused on developing innovative therapies for patients with rare diseases. The company specializes in the research and development of novel treatments that target specific genetic and metabolic disorders. Nivalis leverages advanced scientific methodologies to create solutions that address unmet medical needs, aiming to improve the quality of life for affected individuals through precision medicine and tailored therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nivalis Therapeutics, Inc.. Retrieved from https://idiyas.com/company/nivalis-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]